Top

Current Dermatology Reports

Published in:

15-08-2023 | Allergic Contact Dermatitis | REVIEW

The Future of Patch Testing: Reimbursement Models, Workforce Shortages, and Negotiating in the House of Medicine

Authors: Isha Joshi, Alexandra Flamm

Published in: Current Dermatology Reports | Issue 4/2023

Abstract

Purpose of Review

Patch testing is critical to diagnosing allergic contact dermatitis; however, there are barriers that can prevent prompt comprehensive access, including those affecting reimbursement, insurer challenges, and workforce shortages.

Recent Findings

Multiple reimbursement models exist within various practice types for patch testing. Insurer limits remain a barrier to comprehensive patch testing in many situations; however, advocacy in this area has led to some improvements. Workforce shortages, within medicine overall, as well as in dermatology and contact dermatitis specialists continue to be a concern. Overall, there are multiple ways to engage in advocacy at the local, state, and national levels to help improve patient access to comprehensive patch testing.

Summary

Patch testing is a vital component of appropriate care for allergic contact dermatitis patients. Challenges to ensuring access to patch testing include reimbursement and physician workforce shortages. Advocacy is crucial to addressing these areas, and physician involvement in advocacy efforts is necessary to ensure high-level patient care.

Alinaghi F, Bennike NH, Egeberg A, Thyssen JP, Johansen JD. Prevalence of contact allergy in the general population: a systematic review and meta-analysis. Contact Dermatitis. 2019;80(2):77–85. https://doi.org/10.1111/cod.13119.CrossRefPubMed

Brown C, Yu J. Pediatric allergic contact dermatitis. Immunol allergy Clin N Am. 2021;41(3):393–408. https://doi-org.ezaccess.libraries.psu.edu/10.1016/j.iac.2021.04.004.

Ramirez F, Chren MM, Botto N. A review of the impact of patch testing on quality of life in allergic contact dermatitis. J Am Acad Dermatol. 2017;76(5):1000–4. https://doi.org/10.1016/j.jaad.2016.12.011.CrossRefPubMed

Garg V, Brod B, Gaspari AA. Patch testing: uses, systems, risks/benefits, and its role in managing the patient with contact dermatitis. Clin Dermatol. 2021;39(4):580–90. https://doi.org/10.1016/j.clindermatol.2021.03.005.CrossRefPubMed

American Medical Association. RVS Update Committee (RUC). Am Med Assoc. 2023. https://www.ama-assn.org/about/rvs-update-committee-ruc/rvsupdate-committee-ruc.

CPT 2023 Professional Edition.

•• Zhu TH, Suresh R, Farahnik B, Jeon C, Warshaw E, Scheinman P, et al. Survey of patch test business models in the United States by the American Contact Dermatitis Society. Dermatitis: contact, atopic, occupational, drug. 2018;29(2):85–88. This paper reviews the major patch test reimbursement models utilized by contact dermatitis experts.

Centers for Medicare & Medicaid Services. Search the physician fee schedule. Centers for Medicare & Medicaid Services (CMS). 2023. https://www.cms.gov/medicare/physician-fee-schedule/search/license-agreement?destination=/medicare/physician-fee-schedule/search%3FY%3d0%26T%3d4%26HT%3d0%26CT%3d3%26H1%3d95044%26M%3d5.

Warshaw EM. Reimbursement for patch testing at academic centers: the Achilles’ heel of academic contact dermatitis specialists. Am J Contact Dermat. 2003;14:215-216.

10.

Ogbechie-Godec OA, Mostaghimi A, Nambudiri VE. Skin in the game: existing and upcoming physician payment models in dermatology. J Am Acad Dermatol. 2018;79(1):175–7.CrossRefPubMed

11.

• Rodriguez-Homs LG, Taylor J, Liu B, Green CL, Brod B, Jacob SE, et al. Patch test practice patterns of members of the American Contact Dermatitis Society. Dermatitis: contact, atopic, occupational, drug. 2020;31(4):272–275. This paper highlights the use of expanded patch testing by contact dermatitis experts and its importance in the accurate diagnosis of allergic contact dermatitis.

12.

Chemotechnique MB Diagnostics AB. North American 80 Comprehensive Series NAC-80. Chemotechnique Diagn. 2023. https://www.chemotechnique.se/products/national-series/north-american-80-comprehensive-series/.

13.

Smart Practice Canada. American Core allergen series (ACDS recommended). Smart Pract Can. 2023. https://www.smartpracticecanada.com/shop/style?id=SCSERIESACNA.

14.

Qureshi AA, Awosika O, Nelson K, Brodsky S, Wang H, Ehrlich A. Retrospective review of insurance coverage for patch testing. Ann Allergy Asthma Immunol. 2019;122(5):508–12. https://doi.org/10.1016/j.anai.2019.02.012.CrossRefPubMed

15.

American Contact Dermatitis Society. Practices of patch testing. Am Contact Dermatitis Soc (ACDS). 2023. https://www.contactderm.org/resources/practice-of-patch-testing.

16.

American Academy of Dermatology. Private payer tool. Am Acad Dermatol (AAD). https://www.aad.org/member/practice/drugs/private-payer/payer-tool.

17.

Singh P, Liszewski W. Trends in patch testing by health care providers among US Medicare beneficiaries. Dermatitis: contact, atopic, occupational, drug. 2021;32(6):406–412. https://doi.org/10.1097/DER.0000000000000742.

18.

CE Wheeler Jr briggaman RA, Caro I. Shortage of full-time faculty in dermatology Arch Dermatol. 1977;113(3):297-301.

19.

Zhai L, Motaparthi K. Building successful culture, mission, and vision in dermatology. Clin Dermatol. 2022;40(6):796–801. https://doi.org/10.1016/j.clindermatol.2022.08.011.CrossRefPubMed

20.

Brumbaugh B, Goldman N, Nambudiri V, LaChance AH. The Resident Physician Shortage Reduction Act: an opportunity to address the rural dermatology workforce deficit. J Am Acad Dermatol. 2022;87(6):1461–4. https://doi.org/10.1016/j.jaad.2022.06.032.CrossRefPubMed

21.

• IHS Markit Ltd. The complexities of physician supply and demand: projections from 2019 to 2034. Association of American Medical Colleges (AAMC). 2021. https://www.aamc.org/media/54681/download . This reports highlights trends in the physician workforce and concerns for physician shortages in the near future.

22.

Qian MF, Li S, Honari G, Sarin KY, Chen JK. Sociodemographic disparities in patch testing for commercially insured patients with dermatitis: a retrospective analysis of administrative claims data. J Am Acad Dermatol. 2022;87(6):1411–1413. https://doi-org.ezaccess.libraries.psu.edu/10.1016/j.jaad.2022.08.041.

23.

Gronbeck C, Feng PW, Feng H. Differences in dermatologic patient complexity based on practice setting. J Am Acad Dermatol. 2021;84(2):522–524. https://doi-org.ezaccess.libraries.psu.edu/10.1016/j.jaad.2020.04.151.

24.

Lester J, Wintroub B, Linos E. Disparities in academic dermatology. JAMA Dermatol. 2016;152(8):878–879. https://doi-org.ezaccess.libraries.psu.edu/10.1001/jamadermatol.2016.1533.

25.

Brown C, Yu J. Pediatric allergic contact dermatitis. Immunol Allergy Clin N Am. 2021;41(3):393–408. https://doi-org.ezaccess.libraries.psu.edu/10.1016/j.iac.2021.04.004.

26.

Stephens MR, Murthy AS, McMahon PJ. Wait times, health care touchpoints, and nonattendance in an academic pediatric dermatology clinic. Pediatr Dermatol. 2019;36(6):893–7. https://doi.org/10.1111/pde.13943.CrossRefPubMed

27.

Prindaville B, Horii KA, Siegfried EC, Brandling-Bennett H. Pediatric dermatology workforce in the United States. Pediatr Dermatol. 2019;36(1):166–168. https://doi-org.ezaccess.libraries.psu.edu/10.1111/pde.13684.

28.

Zhang M, Zippin J, Kaffenberger B. Trends and scope of dermatology procedures billed by advanced practice professionals from 2012 through 2015. JAMA Dermatol. 2018;154(9):1040–4. https://doi.org/10.1001/jamadermatol.2018.1768.CrossRefPubMedPubMedCentral

29.

Konda, S., Francis, J., Motaparthi, K., Grant-Kels, J. M., & Group for Research of Corporatization and Private Equity in Dermatology. Future considerations for clinical dermatology in the setting of 21st century American policy reform: corporatization and the rise of private equity in dermatology. J Am Acad Dermatol. 2019;81(1):287-296.e8. https://doi.org/10.1016/j.jaad.2018.09.052.CrossRef

30.

Ehrlich A, Kostecki J, Olkaba H. Trends in dermatology practices and the implications for the workforce. J Am Acad Dermatol. 2017;77(4):746–52. https://doi.org/10.1016/j.jaad.2017.06.030.CrossRefPubMed

31.

• United States Food and Drug Administration. Modernization of Cosmetics Regulation Act of 2022. United States Food and Drug Administration (FDA). 2023. https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022. This source contains all of the details of the newly passed Modernization of Cosmetics Regulation Act.

32.

American Medical Association. National Cosmetics Registry and Regulation H-440.855. 2017. Am Med Assoc (AMA). https://policysearch.amaassn.org/policyfinder/detail/cosmetic?uri=%2FAMADoc%2FHOD.xml-0-3871.xml.

33.

American Medical Association. Specialty organizations seated in our AMA House of Delegates D-600.984. 2022. Am Med Assoc (AMA). https://policysearch.amaassn.org/policyfinder/detail/dermatitis?uri=%2FAMADoc%2Fdirectives.xml-0-1837.xml.

34.

United States Department of Labor. OSH Act of 1970. United States Department of Labor. 2023. https://www.osha.gov/laws-regs/oshact/completeoshact.

35.

Centers for Disease Control and Prevention. Immune, infectious and dermal disease prevention program. 2022. Centers Dis Control Prev (CDC). https://www.cdc.gov/niosh/programs/idid/.

36.

Centers for Disease Control and Prevention. Skin exposures and effects: recommendations and resources. 2022. Centers Dis Control Prev (CDC). https://www.cdc.gov/niosh/topics/skin/recommendations.html.

Title: The Future of Patch Testing: Reimbursement Models, Workforce Shortages, and Negotiating in the House of Medicine
Authors: Isha Joshi
Alexandra Flamm
Publication date: 15-08-2023
Publisher: Springer US
Keyword: Allergic Contact Dermatitis
Published in: Current Dermatology Reports / Issue 4/2023
Electronic ISSN: 2162-4933
DOI: https://doi.org/10.1007/s13671-023-00398-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The Future of Patch Testing: Reimbursement Models, Workforce Shortages, and Negotiating in the House of Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 4/2023

Correction: Oral Minoxidil Therapy in Hair Loss: Where Do We Stand?

JAK Inhibitor Use for the Inpatient Dermatologist

Mpox: Diagnosis and Management for the Inpatient Dermatologist

Incidence and Characteristics of Melanoma in Multiple Sclerosis Patients Treated With Fingolimod: A Systematic Review

Immune Checkpoint Inhibitors and Systemic Side Effects: Overview for the Inpatient Dermatologist

Toward a Molecular Diagnosis: Looking Under the Skin at Allergic Contact Dermatitis